About Pelvalon
Pelvalon is a company based in Sunnyvale (United States) founded in 2010 was acquired by Laborie Medical in October 2021. Pelvalon offers products and services including Eclipse System, NXT Family of Urodynamics Systems, Optilume BPH Catheter System, and alpHaONE Wireless pH Capsule. Pelvalon operates in a competitive market with competitors including Axonics, Averto Medical, Boomerang Medical, Signum Surgical and NovoGI, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Laborie Medical Technologies Corp.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Laborie Medical
& 1 more
-
Employee Count
Not available
-
Acquired by
Laborie Medical
(Oct 13, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pelvalon
Pelvalon offers a comprehensive portfolio of products and services, including Eclipse System, NXT Family of Urodynamics Systems, Optilume BPH Catheter System, and alpHaONE Wireless pH Capsule.
Treats fecal incontinence through non-surgical vaginal insert.
Assists in evaluating urinary tract function in clinical settings.
Manages benign prostatic hyperplasia with drug-coated balloon.
Monitors reflux in gastroenterology patients effectively.
Funding Insights of Pelvalon
Investors in Pelvalon
Pelvalon has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Laborie Medical and Stanford Biodesign.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Project-based bio-design courses are offered to Stanford graduates and post-docs.
|
Locked | Locked | Locked | |
|
Medical products for female lower urinary tract dysfunctions are provided.
|
Locked | Locked | Locked |
Investor details for Pelvalon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pelvalon
Investment portfolio details for Pelvalon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pelvalon
Detailed financials for Pelvalon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pelvalon Comparisons
Peer comparison for Pelvalon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pelvalon
Pelvalon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Averto Medical, Boomerang Medical, Signum Surgical and NovoGI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal disease patients are developed.
|
|
| Locked | Locked | Locked |
Bioelectronic devices are developed for autoimmune disease treatment.
|
|
| Locked | Locked | Locked |
Surgically implanted devices for perianal fistula treatment are provided.
|
|
| Locked | Locked | Locked |
Provides compression anastomosis devices for GI disease management.
|
|
| Locked | Locked | Locked |
A non-invasive medical device for chronic constipation treatment is developed.
|
Detailed competitors of Pelvalon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pelvalon
Complete news archive for Pelvalon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pelvalon
Pelvalon was founded in 2010.
Pelvalon is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Eclipse is the a vaginal insert designed to provide bowel control in women with fecal incontinence. The insert is placed in the same location as a tampon or a diaphragm, and can be removed at any time. A detachable and discreet pump is used to inflate and deflate a balloon on the insert. The balloon is designed to control the rectum and prevent stool from passing when the patient is not ready for it. When the patient is ready to have a bowel movement, they may simply deflate the balloon to pass stool.
Pelvalon's top competitors include Axonics, Signum Surgical and Exero Medical.
Pelvalon offers Eclipse System, NXT Family of Urodynamics Systems, Optilume BPH Catheter System, and alpHaONE Wireless pH Capsule.
Pelvalon has 2 investors. Key investors include Laborie Medical, and Stanford Biodesign.